Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Processa Pharmaceuticals (PCSA) Q3 2024 Earnings
PCSA
28
Aug
Confirmed
Q2 2023
Q3 2023
Q2 2024
Q3 2024
-1.18
-0.81
-0.45
-0.08
Details
Expected EPS
-1.01
Actual EPS
-1.01
Surprise EPS
0
Surprise Percent
+0%
Description
Processa Pharmaceuticals (PCSA) has reported earnings of -1.01 per share for Q3 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login